SCHEMBL432008

SCHEMBL432008

CNC(=O)c1cccc(N)c1NC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.49
GAA P10253 2/20 0.47
ALDH1A1 P00352 6/20 0.43
HSD17B10 Q99714 3/20 0.43
CFTR P13569 1/20 0.43
KDM4E B2RXH2 6/20 0.41
HPGD P15428 4/20 0.41
NSD2 O96028 2/20 0.41
MAPT P10636 1/20 0.40
MMP2 P08253 1/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
MTNR1A P48039 1/20 0.40
CXCR2 P25025 1/20 0.39
BRD4 O60885 1/20 0.39
BRD2 P25440 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25022848 0.83 ALDH1A1 (0.44) GAAALDH1A1HSD17B10CFTRKDM4E
SCHEMBL306292 0.83 MMP2 (0.55) GAAALDH1A1HSD17B10CFTRKDM4E
Hydrochloric Acid SCHEMBL7425514 0.81 MMP2 (0.53) GAAALDH1A1HSD17B10CFTRKDM4E
SCHEMBL5252014 0.81 PLK1 (0.52) PLK1GAAALDH1A1HSD17B10CFTR
SCHEMBL2506377 0.80 PLK1 (0.41) PLK1GAAALDH1A1HSD17B10CFTR
SCHEMBL375579 0.80 ALDH1A1 (0.59) PLK1GAAALDH1A1HSD17B10CFTR
SCHEMBL2085084 0.80 ALDH1A1 (0.65) GAAALDH1A1HSD17B10CFTRKDM4E
SCHEMBL12260753 0.79 MMP2 (0.60) PLK1GAAALDH1A1HSD17B10CFTR
SCHEMBL2299529 0.79 PLK1 (0.50) PLK1GAAALDH1A1HSD17B10CFTR
Hydrochloric Acid SCHEMBL27744263 0.79 ALDH1A1 (0.57) PLK1GAAALDH1A1HSD17B10CFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9382226-B2 Aldosterone synthase inhibitors MERCK SHARP & DOHME CORP. (US) 2016-07-05 US disclosed
US-9382226-B2 Aldosterone synthase inhibitors MERCK SHARP & DOHME CORP. (US) 2016-07-05 US disclosed
US-9382226-B2 Aldosterone synthase inhibitors MERCK SHARP & DOHME CORP. (US) 2016-07-05 US disclosed
US-20130317057-A1 ALDOSTERONE SYNTHASE INHIBITORS MERCK SHARP & DOHME LLC 2013-11-28 US disclosed
EP-2595482-A1 ALDOSTERONE SYNTHASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2013-05-29 EP disclosed
WO-2012012478-A1 ALDOSTERONE SYNTHASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2012-01-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130317057-A1 ALDOSTERONE SYNTHASE INHIBITORS HSD11B1, CYP11B2, HSD11B2 PLK1 3476/4885GAA 2500/4885ALDH1A1 300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.